751 related articles for article (PubMed ID: 23933230)
21. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
22. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
23. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
Konstantinidis IT; Vinuela EF; Tang LH; Klimstra DS; D'Angelica MI; Dematteo RP; Kingham TP; Fong Y; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2013 Oct; 20(11):3643-7. PubMed ID: 23748606
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
25. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
Chang X; Yu C; Li J; Yu S; Chen J
Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
[No Abstract] [Full Text] [Related]
26. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
Haugk B
Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
[TBL] [Abstract][Full Text] [Related]
28. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.
Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P
Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856
[TBL] [Abstract][Full Text] [Related]
29. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
30. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
[TBL] [Abstract][Full Text] [Related]
33. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
35. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
36. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
37. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma.
Ryu JK; Hong SM; Karikari CA; Hruban RH; Goggins MG; Maitra A
Pancreatology; 2010; 10(1):66-73. PubMed ID: 20332664
[TBL] [Abstract][Full Text] [Related]
38. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
Cote GA; Gore AJ; McElyea SD; Heathers LE; Xu H; Sherman S; Korc M
Am J Gastroenterol; 2014 Dec; 109(12):1942-52. PubMed ID: 25350767
[TBL] [Abstract][Full Text] [Related]
39. Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma.
Jarboe EA; Layfield LJ
Diagn Cytopathol; 2011 Aug; 39(8):575-81. PubMed ID: 20730891
[TBL] [Abstract][Full Text] [Related]
40. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]